Cargando…
Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial
BACKGROUND: Despite shortening vasopressor use in shock, hydrocortisone administration remains controversial, with potential harm to the immune system. Few studies have assessed the impact of hydrocortisone on the transcriptional response in shock, and we are lacking data on burn shock. Our objectiv...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473974/ https://www.ncbi.nlm.nih.gov/pubmed/28623938 http://dx.doi.org/10.1186/s13054-017-1743-9 |
_version_ | 1783244385457012736 |
---|---|
author | Plassais, Jonathan Venet, Fabienne Cazalis, Marie-Angélique Le Quang, Diane Pachot, Alexandre Monneret, Guillaume Tissot, Sylvie Textoris, Julien |
author_facet | Plassais, Jonathan Venet, Fabienne Cazalis, Marie-Angélique Le Quang, Diane Pachot, Alexandre Monneret, Guillaume Tissot, Sylvie Textoris, Julien |
author_sort | Plassais, Jonathan |
collection | PubMed |
description | BACKGROUND: Despite shortening vasopressor use in shock, hydrocortisone administration remains controversial, with potential harm to the immune system. Few studies have assessed the impact of hydrocortisone on the transcriptional response in shock, and we are lacking data on burn shock. Our objective was to assess the hydrocortisone-induced transcriptional modulation in severe burn shock, particularly modulation of the immune response. METHODS: We collected whole blood samples during a randomized controlled trial assessing the efficacy of hydrocortisone administration in burn shock. Using whole genome microarrays, we first compared burn patients (n = 32) from the placebo group to healthy volunteers to describe the transcriptional modulation induced by burn shock over the first week. Then we compared burn patients randomized for either hydrocortisone administration or placebo, to assess hydrocortisone-induced modulation. RESULTS: Study groups were similar in terms of severity and major outcomes, but shock duration was significantly reduced in the hydrocortisone group. Many genes (n = 1687) were differentially expressed between burn patients and healthy volunteers, with 85% of them exhibiting a profound and persistent modulation over seven days. Interestingly, we showed that hydrocortisone enhanced the shock-associated repression of adaptive, but also innate immunity. CONCLUSIONS: We found that the initial host response to burn shock encompasses wide and persistent modulation of gene expression, with profound modulation of pathways associated with metabolism and immunity. Importantly, hydrocortisone administration may worsen the immunosuppression associated with severe injury. These data should be taken into account in the risk ratio of hydrocortisone administration in patients with inflammatory shock. TRIAL REGISTRATION: ClinicalTrials.gov, NCT00149123. Registered on 6 September 2005. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1743-9) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5473974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-54739742017-06-21 Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial Plassais, Jonathan Venet, Fabienne Cazalis, Marie-Angélique Le Quang, Diane Pachot, Alexandre Monneret, Guillaume Tissot, Sylvie Textoris, Julien Crit Care Research BACKGROUND: Despite shortening vasopressor use in shock, hydrocortisone administration remains controversial, with potential harm to the immune system. Few studies have assessed the impact of hydrocortisone on the transcriptional response in shock, and we are lacking data on burn shock. Our objective was to assess the hydrocortisone-induced transcriptional modulation in severe burn shock, particularly modulation of the immune response. METHODS: We collected whole blood samples during a randomized controlled trial assessing the efficacy of hydrocortisone administration in burn shock. Using whole genome microarrays, we first compared burn patients (n = 32) from the placebo group to healthy volunteers to describe the transcriptional modulation induced by burn shock over the first week. Then we compared burn patients randomized for either hydrocortisone administration or placebo, to assess hydrocortisone-induced modulation. RESULTS: Study groups were similar in terms of severity and major outcomes, but shock duration was significantly reduced in the hydrocortisone group. Many genes (n = 1687) were differentially expressed between burn patients and healthy volunteers, with 85% of them exhibiting a profound and persistent modulation over seven days. Interestingly, we showed that hydrocortisone enhanced the shock-associated repression of adaptive, but also innate immunity. CONCLUSIONS: We found that the initial host response to burn shock encompasses wide and persistent modulation of gene expression, with profound modulation of pathways associated with metabolism and immunity. Importantly, hydrocortisone administration may worsen the immunosuppression associated with severe injury. These data should be taken into account in the risk ratio of hydrocortisone administration in patients with inflammatory shock. TRIAL REGISTRATION: ClinicalTrials.gov, NCT00149123. Registered on 6 September 2005. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13054-017-1743-9) contains supplementary material, which is available to authorized users. BioMed Central 2017-06-16 /pmc/articles/PMC5473974/ /pubmed/28623938 http://dx.doi.org/10.1186/s13054-017-1743-9 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Plassais, Jonathan Venet, Fabienne Cazalis, Marie-Angélique Le Quang, Diane Pachot, Alexandre Monneret, Guillaume Tissot, Sylvie Textoris, Julien Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial |
title | Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial |
title_full | Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial |
title_fullStr | Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial |
title_full_unstemmed | Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial |
title_short | Transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial |
title_sort | transcriptome modulation by hydrocortisone in severe burn shock: ancillary analysis of a prospective randomized trial |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473974/ https://www.ncbi.nlm.nih.gov/pubmed/28623938 http://dx.doi.org/10.1186/s13054-017-1743-9 |
work_keys_str_mv | AT plassaisjonathan transcriptomemodulationbyhydrocortisoneinsevereburnshockancillaryanalysisofaprospectiverandomizedtrial AT venetfabienne transcriptomemodulationbyhydrocortisoneinsevereburnshockancillaryanalysisofaprospectiverandomizedtrial AT cazalismarieangelique transcriptomemodulationbyhydrocortisoneinsevereburnshockancillaryanalysisofaprospectiverandomizedtrial AT lequangdiane transcriptomemodulationbyhydrocortisoneinsevereburnshockancillaryanalysisofaprospectiverandomizedtrial AT pachotalexandre transcriptomemodulationbyhydrocortisoneinsevereburnshockancillaryanalysisofaprospectiverandomizedtrial AT monneretguillaume transcriptomemodulationbyhydrocortisoneinsevereburnshockancillaryanalysisofaprospectiverandomizedtrial AT tissotsylvie transcriptomemodulationbyhydrocortisoneinsevereburnshockancillaryanalysisofaprospectiverandomizedtrial AT textorisjulien transcriptomemodulationbyhydrocortisoneinsevereburnshockancillaryanalysisofaprospectiverandomizedtrial |